Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Get the Alerts
Claim MarketBeat All Access Sale Promotion

Truist Financial's Rating of Agios Pharmaceuticals on 10/7/2026

On October 7, 2026, Truist Financial updated its outlook on Agios Pharmaceuticals (NASDAQ:AGIO) with the action "Lower Price Target", setting a price target of $37.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Truist Financial Corporation

DateCompanyAction
10/27/2026
Zymeworks Inc. stock logo
ZYME
Zymeworks
Set Price Target
10/27/2026
Xencor, Inc. stock logo
XNCR
Xencor
Boost Price Target
10/27/2026
Quanta Services, Inc. stock logo
PWR
Quanta Services
Boost Price Target
10/27/2026
Clearwater Paper Corporation stock logo
CLW
Clearwater Paper
Lower Price Target
10/27/2026
SL Green Realty Corporation stock logo
SLG
SL Green Realty
Lower Price Target
10/27/2026
PPL Corporation stock logo
PPL
PPL
Initiated Coverage
More Ratings From Truist Financial Corporation